We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Trevena Inc | NASDAQ:TRVN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0031 | 0.76% | 0.4126 | 0.3804 | 2.30 | 0.4352 | 0.38 | 0.4352 | 76,312 | 05:00:04 |
The Company will host a conference call and webcast with the investment community on Wednesday, March 13th at 8:00 a.m. Eastern Time featuring remarks by Carrie Bourdow, President and CEO, Mark Demitrack, SVP and Chief Medical Officer, and John Hamill, VP of Finance.
What: | Trevena Fourth Quarter and Full Year 2018 Results Conference Call |
Date: | Wednesday, March 13, 2019 |
Time: | 8:00 a.m. ET |
Live Call: | Toll-Free: (855) 465-0180International: (484) 756-4313 |
Webcast: | investors.trevena.com |
Replay: | Toll-Free: (855) 859-2056 International: (404) 537-3406 Conference ID: 3496246(Available approximately one hour after the completion of the live call until 11:59 p.m. ET on March 27, 2019) |
About TrevenaTrevena, Inc. is a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in pain. The Company has three novel and differentiated investigational drug candidates, including IV oliceridine, for the management of moderate to severe acute pain in hospitals, TRV250 for the treatment of acute migraine, and TRV734 for pain and/or management of opioid dependence. In its preclinical programs, Trevena is evaluating a set of novel S1P receptor modulators that may offer a new, non-opioid approach to managing chronic pain.
For more information, please contact:
Investor Contact:Valter Pinto / Allison SossKCSA Strategic CommunicationsPhone: 212-896-1254 / 212-896-1267Email: IR@trevena.com
Company Contact:Bob Yoder, SVP and Chief Business OfficerTrevena, Inc.Phone: 610-354-8840
1 Year Trevena Chart |
1 Month Trevena Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions